TechTarget Inc - Quarter Report: 2023 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 1-33472
TECHTARGET, INC.
(Exact name of registrant as specified in its charter)
Delaware |
04-3483216 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
275 Grove Street Newton, Massachusetts |
02466 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (617) 431-9200
Former name, former address and formal fiscal year, if changed since last report: Not applicable
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered |
Common Stock, $0.001 Par Value |
TTGT |
Nasdaq Global Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
Emerging growth company |
|
☐ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 5, 2023, the registrant had 28,071,521 shares of common stock, $0.001 par value per share, outstanding.
TABLE OF CONTENTS
Item |
|
|
|
Page |
|
|
|
|
|
PART I. |
|
|
|
|
Item 1. |
|
|
3 |
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 |
|
3 |
|
|
|
4 |
|
|
|
|
5 |
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 |
|
6 |
|
|
|
7 |
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
22 |
Item 3. |
|
|
33 |
|
Item 4. |
|
|
34 |
|
|
|
|
|
|
PART II. |
|
|
|
|
Item 1. |
|
|
35 |
|
Item 1A. |
|
|
35 |
|
Item 2. |
|
|
36 |
|
Item 6. |
|
|
37 |
|
|
|
|
38 |
2
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
TechTarget, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
|
|
March 31, |
|
|
December 31, |
|
||
Assets |
|
(Unaudited) |
|
|
(Unaudited) |
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
307,089 |
|
|
$ |
344,523 |
|
Short-term investments |
|
|
45,590 |
|
|
|
20,210 |
|
Accounts receivable, net of allowance for doubtful accounts of $4,778 and $4,494 respectively |
|
|
51,375 |
|
|
|
60,359 |
|
Prepaid expenses and other current assets |
|
|
7,787 |
|
|
|
5,745 |
|
Total current assets |
|
|
411,841 |
|
|
|
430,837 |
|
Property and equipment, net |
|
|
23,271 |
|
|
|
22,507 |
|
Goodwill |
|
|
193,009 |
|
|
|
192,227 |
|
Intangible assets, net |
|
|
94,386 |
|
|
|
95,517 |
|
Operating lease assets with right-of-use |
|
|
19,510 |
|
|
|
20,039 |
|
Deferred tax assets |
|
|
4,136 |
|
|
|
2,945 |
|
Other assets |
|
|
649 |
|
|
|
645 |
|
Total assets |
|
$ |
746,802 |
|
|
$ |
764,717 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
3,052 |
|
|
$ |
3,298 |
|
Current operating lease liabilities |
|
|
3,896 |
|
|
|
4,099 |
|
Accrued expenses and other current liabilities |
|
|
6,580 |
|
|
|
10,935 |
|
Accrued compensation expenses |
|
|
1,550 |
|
|
|
4,643 |
|
Income taxes payable |
|
|
9,974 |
|
|
|
7,827 |
|
Contract liabilities |
|
|
22,350 |
|
|
|
27,086 |
|
Total current liabilities |
|
|
47,402 |
|
|
|
57,888 |
|
Non-current operating lease liabilities |
|
|
19,609 |
|
|
|
20,371 |
|
Convertible senior notes |
|
|
456,321 |
|
|
|
455,694 |
|
Deferred tax liabilities |
|
|
13,448 |
|
|
|
13,290 |
|
Total liabilities |
|
|
536,780 |
|
|
|
547,243 |
|
|
|
|
|
|
|
|||
Stockholders’ equity: |
|
|
|
|
|
|
||
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding |
|
|
— |
|
|
|
— |
|
Common stock, $0.001 par value; 100,000,000 shares authorized; 58,014,065 and 57,919,501 shares issued, respectively; 28,535,450 and 29,023,093 shares outstanding, respectively |
|
|
58 |
|
|
|
58 |
|
Treasury stock, at cost; 29,478,615 and 28,896,408 shares, respectively |
|
|
(303,876 |
) |
|
|
(278,876 |
) |
Additional paid-in capital |
|
|
439,269 |
|
|
|
425,458 |
|
Accumulated other comprehensive loss |
|
|
(7,445 |
) |
|
|
(9,537 |
) |
Retained earnings |
|
|
82,016 |
|
|
|
80,371 |
|
Total stockholders’ equity |
|
|
210,022 |
|
|
|
217,474 |
|
Total liabilities and stockholders’ equity |
|
$ |
746,802 |
|
|
$ |
764,717 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
3
TechTarget, Inc.
Condensed Consolidated Statements of Income and Comprehensive Income
(in thousands, except per share data)
|
|
For the Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2023 |
|
|
2022 |
|
||
|
|
(Unaudited) |
|
|
(Unaudited) |
|
||
Revenue |
|
$ |
57,114 |
|
|
$ |
68,165 |
|
Cost of revenue(1) |
|
|
17,350 |
|
|
|
17,846 |
|
Amortization of acquired technology |
|
|
673 |
|
|
|
745 |
|
Gross profit |
|
|
39,091 |
|
|
|
49,574 |
|
Operating expenses: |
|
|
|
|
|
|
||
Selling and marketing(1) |
|
|
24,756 |
|
|
|
24,255 |
|
Product development(1) |
|
|
2,609 |
|
|
|
3,118 |
|
General and administrative(1) |
|
|
7,918 |
|
|
|
7,842 |
|
Depreciation, excluding depreciation of $845 and $622, respectively, included in cost of revenue |
|
|
2,000 |
|
|
|
1,665 |
|
Amortization |
|
|
1,493 |
|
|
|
2,012 |
|
Total operating expenses |
|
|
38,776 |
|
|
|
38,892 |
|
Operating income |
|
|
315 |
|
|
|
10,682 |
|
Interest and other income (expense), net |
|
|
2,757 |
|
|
|
(560 |
) |
Income before provision for income taxes |
|
|
3,072 |
|
|
|
10,122 |
|
Provision for income taxes |
|
|
1,427 |
|
|
|
2,958 |
|
Net income |
|
$ |
1,645 |
|
|
$ |
7,164 |
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
||
Unrealized income (loss) on investments (net of tax provision effect of $18 and $(20), respectively) |
|
$ |
63 |
|
|
$ |
(69 |
) |
Foreign currency translation gain (loss) |
|
|
2,029 |
|
|
|
(2,695 |
) |
Other comprehensive income (loss) |
|
|
2,092 |
|
|
|
(2,764 |
) |
Comprehensive income |
|
$ |
3,737 |
|
|
$ |
4,400 |
|
Net income per common share: |
|
|
|
|
|
|
||
Basic |
|
$ |
0.06 |
|
|
$ |
0.24 |
|
Diluted |
|
$ |
0.06 |
|
|
$ |
0.23 |
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
||
Basic |
|
|
28,757 |
|
|
|
29,708 |
|
Diluted |
|
|
28,953 |
|
|
|
34,414 |
|
Cost of revenue |
|
$ |
821 |
|
|
$ |
639 |
|
Selling and marketing |
|
|
7,537 |
|
|
|
5,067 |
|
Product development |
|
|
460 |
|
|
|
480 |
|
General and administrative |
|
|
3,458 |
|
|
|
3,469 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
4
TechTarget, Inc.
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands, except share and per share data)
(Unaudited)
|
|
Common Stock |
|
|
Treasury Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Number of |
|
|
$0.001 |
|
|
Number of |
|
|
Cost |
|
|
Additional |
|
|
Accumulated |
|
|
Retained |
|
|
Total |
|
||||||||
Balance, December 31, 2022 |
|
|
57,919,501 |
|
|
$ |
58 |
|
|
|
28,896,408 |
|
|
$ |
(278,876 |
) |
|
$ |
425,458 |
|
|
$ |
(9,537 |
) |
|
$ |
80,371 |
|
|
$ |
217,474 |
|
Issuance of common stock from exercise of options |
|
|
2,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
18 |
|
|
|
— |
|
|
|
— |
|
|
|
18 |
|
Issuance of common stock from restricted stock awards |
|
|
91,152 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Purchase of common stock through stock buyback |
|
|
— |
|
|
|
— |
|
|
|
581,295 |
|
|
|
(25,000 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(25,000 |
) |
Impact of net settlements |
|
|
912 |
|
|
|
— |
|
|
|
912 |
|
|
|
— |
|
|
|
(177 |
) |
|
|
— |
|
|
|
— |
|
|
|
(177 |
) |
Excise Tax on repurchased shares |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(206 |
) |
|
|
— |
|
|
|
— |
|
|
|
(206 |
) |
Stock-based compensation expense(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
14,176 |
|
|
|
— |
|
|
|
— |
|
|
|
14,176 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Unrealized gain on investments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
63 |
|
|
|
— |
|
|
|
63 |
|
Unrealized gain on foreign currency exchange |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,029 |
|
|
|
— |
|
|
|
2,029 |
|
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,645 |
|
|
|
1,645 |
|
Balance, March 31, 2023 |
|
|
58,014,065 |
|
|
$ |
58 |
|
|
|
29,478,615 |
|
|
$ |
(303,876 |
) |
|
$ |
439,269 |
|
|
$ |
(7,445 |
) |
|
$ |
82,016 |
|
|
$ |
210,022 |
|
|
|
Common Stock |
|
|
Treasury Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Number of |
|
|
$0.001 |
|
|
Number of |
|
|
Cost |
|
|
Additional |
|
|
Accumulated |
|
|
Retained |
|
|
Total |
|
||||||||
Balance, December 31, 2021 |
|
|
57,144,740 |
|
|
$ |
57 |
|
|
|
27,510,842 |
|
|
$ |
(199,796 |
) |
|
$ |
383,436 |
|
|
$ |
298 |
|
|
$ |
38,762 |
|
|
$ |
222,757 |
|
Issuance of common stock from restricted stock awards |
|
|
122,571 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Purchase of common stock through stock buyback |
|
|
— |
|
|
|
— |
|
|
|
4,614 |
|
|
|
(323 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(323 |
) |
Impact of net settlements |
|
|
1,340 |
|
|
|
— |
|
|
|
1,340 |
|
|
|
— |
|
|
|
(4,382 |
) |
|
|
— |
|
|
|
— |
|
|
|
(4,382 |
) |
Stock-based compensation expense(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
18,744 |
|
|
|
— |
|
|
|
— |
|
|
|
18,744 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Unrealized loss on investments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(69 |
) |
|
|
— |
|
|
|
(69 |
) |
Unrealized loss on foreign currency exchange |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,695 |
) |
|
|
— |
|
|
|
(2,695 |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
7,164 |
|
|
|
7,164 |
|
Balance, March 31, 2022 |
|
|
57,268,651 |
|
|
$ |
57 |
|
|
|
27,516,796 |
|
|
$ |
(200,119 |
) |
|
$ |
397,798 |
|
|
$ |
(2,466 |
) |
|
$ |
45,926 |
|
|
$ |
241,196 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
5
TechTarget, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
|
|
For the Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2023 |
|
|
2022 |
|
||
|
|
(Unaudited) |
|
|||||
Operating activities: |
|
|
|
|
|
|
||
Net income |
|
$ |
1,645 |
|
|
$ |
7,164 |
|
Adjustments to reconcile net income to net cash provided by operating |
|
|
|
|
|
|
||
Depreciation |
|
|
2,845 |
|
|
|
2,287 |
|
Amortization |
|
|
2,166 |
|
|
|
2,757 |
|
Provision for bad debt |
|
|
758 |
|
|
|
170 |
|
Stock-based compensation |
|
|
12,276 |
|
|
|
9,655 |
|
Amortization of debt issuance costs |
|
|
627 |
|
|
|
624 |
|
Deferred tax benefit |
|
|
(1,298 |
) |
|
|
(1,420 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
8,294 |
|
|
|
(174 |
) |
Operating lease assets with right of use |
|
|
390 |
|
|
|
716 |
|
Prepaid expenses and other current assets |
|
|
(2,033 |
) |
|
|
(536 |
) |
Other assets |
|
|
(4 |
) |
|
|
252 |
|
Accounts payable |
|
|
(250 |
) |
|
|
(1,562 |
) |
Income taxes payable |
|
|
2,173 |
|
|
|
4,189 |
|
Accrued expenses and other current liabilities |
|
|
(2,445 |
) |
|
|
2,209 |
|
Accrued compensation expenses |
|
|
(1,209 |
) |
|
|
(2,669 |
) |
Operating lease liabilities with right of use |
|
|
(874 |
) |
|
|
(740 |
) |
Contract liabilities |
|
|
(4,843 |
) |
|
|
7,413 |
|
Other liabilities |
|
|
— |
|
|
|
(2,778 |
) |
Net cash provided by operating activities |
|
|
18,218 |
|
|
|
27,557 |
|
Investing activities: |
|
|
|
|
|
|
||
Purchases of property and equipment, and other capitalized assets, net |
|
|
(3,548 |
) |
|
|
(3,578 |
) |
Purchases of investments |
|
|
(25,299 |
) |
|
|
(33 |
) |
Net cash used in investing activities |
|
|
(28,847 |
) |
|
|
(3,611 |
) |
Financing activities: |
|
|
|
|
|
|
||
Tax withholdings related to net share settlements |
|
|
(177 |
) |
|
|
(4,382 |
) |
Purchase of treasury shares and related costs |
|
|
(25,000 |
) |
|
|
(323 |
) |
Proceeds from stock option exercises |
|
|
18 |
|
|
|
— |
|
Payment of earnout liabilities |
|
|
(2,267 |
) |
|
|
(5,206 |
) |
Net cash used in financing activities |
|
|
(27,426 |
) |
|
|
(9,911 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
621 |
|
|
|
(525 |
) |
Net increase (decrease) in cash and cash equivalents |
|
|
(37,434 |
) |
|
|
13,510 |
|
Cash and cash equivalents at beginning of period |
|
|
344,523 |
|
|
|
361,623 |
|
Cash and cash equivalents at end of period |
|
$ |
307,089 |
|
|
$ |
375,133 |
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
||
Cash paid for taxes, net |
|
$ |
598 |
|
|
$ |
137 |
|
Schedule of non-cash investing and financing activities: |
|
|
|
|
|
|
||
Right of use assets and lease liabilities |
|
$ |
314 |
|
|
$ |
— |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
6
TechTarget, Inc.
Notes to Condensed Consolidated Financial Statements
(In thousands, except share and per share data, where otherwise noted, or instances where expressed in millions)
1. Organization and Operations
TechTarget, Inc. and its subsidiaries (collectively, the “Company”) is a global data and analytics leader and software provider for buyers of purchase intent-driven marketing and sales data for enterprise technology vendors. The Company’s service offerings enable technology vendors to better identify, reach and influence corporate information technology (“IT”) decision-makers actively researching specific IT purchases. The Company improves vendors’ ability to impact these audiences for business growth using advanced targeting, analytics and data services complemented by customized marketing programs that integrate demand generation, brand advertising techniques, and content curation and creation. The Company operates a network of approximately 150 websites and 1,000 webinars and virtual event channels, which each focus on a specific IT sector such as storage, security or networking. IT and business professionals have become increasingly specialized, and they have come to rely on the Company’s sector-specific websites and webinars and virtual event channels for purchasing decision support. The Company’s content platforms enable IT and business professionals to navigate the complex and rapidly changing IT landscape where purchasing decisions can have significant financial and operational consequences. At critical stages of the purchase decision process, these content offerings through different channels meet IT and business professionals’ needs for expert, peer and IT vendor information and provide platforms on which business-to-business technology companies can launch targeted marketing campaigns which generate measurable return on investment. Based upon the logical clustering of members and users’ respective job responsibilities and the marketing focus of the products being promoted by the Company’s customers, the Company categorizes its content offerings to address the key market opportunities and audience extensions across a portfolio of distinct market categories: Security; Networking; Storage; Data Center and Virtualization Technologies; CIO/IT Strategy; Business Applications and Analytics; Application Architecture and Development; and ANCL Channel.
2. Summary of Significant Accounting Policies
The accompanying condensed consolidated financial statements reflect the application of certain significant accounting policies as described below and elsewhere in these notes to condensed consolidated financial statements. The Company’s critical accounting policies are those that affect its more significant judgments used in the preparation of its condensed consolidated financial statements. A description of the Company’s critical accounting policies and estimates is contained in its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and in this note to the condensed consolidated financial statements.
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, TechTarget Securities Corporation (“TSC”), TechTarget Limited, TechTarget (HK) Limited (“TTGT HK”), TechTarget (Australia) Pty Ltd., TechTarget (Singapore) Pte Ltd., E-Magine Médias SAS (“LeMagIT”), TechTarget Germany GmbH, and BrightTALK Limited and its wholly owned subsidiary, BrightTALK, Inc. (together “BrightTALK”). TSC is a Massachusetts corporation. TechTarget Limited is a subsidiary doing business principally in the United Kingdom. TTGT HK is a subsidiary incorporated in Hong Kong in order to facilitate the Company’s activities in the Asia-Pacific region. TechTarget (Australia) Pty Ltd. and TechTarget (Singapore) Pte Ltd. are the entities through which the Company does business in Australia and Singapore, respectively; LeMagIT and TechTarget Germany GmbH, both wholly-owned subsidiaries of TechTarget Limited, are entities through which the Company does business in France and Germany, respectively. BrightTALK are the entities through which the Company conducts business related to its BrightTALK webinar and virtual event platform.
7
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted (Generally Accepted Accounting Principles or “U.S. GAAP”) in the United States (“U.S.”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. All adjustments, which, in the opinion of management, are considered necessary for a fair presentation of the results of operations for the periods shown, are of a normal, recurring nature and have been reflected in the condensed consolidated financial statements. The results of operations for the periods presented are not necessarily indicative of results to be expected for any other interim periods or for the full year. The information included in these condensed consolidated financial statements should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the condensed consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Foreign Currency Translation
The functional currency of the Company’s major foreign subsidiaries is generally the local currency. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as a separate component on the Condensed Consolidated Statement of Comprehensive Income as an element of accumulated other comprehensive income (loss). Foreign currency transaction gains and losses are included in interest and other income (expense), net in the Condensed Consolidated Statement of Income. All assets and liabilities denominated in foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate during the period.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to revenue, long-lived assets, goodwill, the allowance for doubtful accounts, stock-based compensation, earnouts, self-insurance accruals, the allocation of purchase price to intangibles and goodwill, and income taxes. The Company reduces its accounts receivable for an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses. Estimates of the carrying value of certain assets and liabilities are based on historical experience and on various other assumptions that the Company believes to be reasonable. Actual results could differ from those estimates.
Revenue Recognition
The Company generates its revenue from the sale of targeted marketing and advertising campaigns, which it delivers via its network of websites, webinar and virtual events channels, and our data analytic services and solutions. Revenue is recognized when performance obligations are satisfied by transferring promised goods or services to customers, as determined by applying a five-step process consisting of: a) identifying the contract, or contracts, with a customer, b) identifying the performance obligations in the contract, c) determining the transaction price, d) allocating the transaction price to the performance obligations in the contract, and e) recognizing revenue when, or as, performance obligations are satisfied.
Cash and Cash Equivalents
The Company considers all highly liquid investments with original or remaining maturities of three months or less on the purchase date to be cash equivalents. Cash and cash equivalents carrying value approximate fair value and consist primarily of bank deposits and government backed money market funds.
Accounts Receivable
We maintain an allowance for credit losses for expected uncollectible accounts receivable, which is recorded as an offset to accounts receivable and changes in such are classified as general and administrative expense in the Condensed Consolidated Statements of Income and Comprehensive Income. We assess collectability by reviewing accounts receivable on an individual basis when we identify specific customers with known disputes, overdue amounts or collectability issues and also reserve for losses on all accounts based on historical information, current market conditions and reasonable and supportable forecasts of future economic conditions to
8
inform adjustments to historical loss data. In determining the amount of the allowance for credit losses, we consider historical collectability based on past due status and make judgments about the creditworthiness of customers based on ongoing credit evaluations.
At March 31, 2023, the Company’s collectability assessment includes the business and market disruptions caused by macro-economic uncertainty currently being experienced in the technology sector and estimates of expected emerging credit and collectability trends. The continued volatility in market conditions and evolving shifts in credit trends are difficult to predict, causing variability and volatility that may have a material impact on our allowance for credit losses in future periods.
Fair Value of Financial Instruments
Financial instruments consist of cash and cash equivalents, short-term investments, accounts receivable, accounts payable, long-term debt and contingent consideration. Due to their short-term nature and liquidity, the carrying value of these instruments, with the exception of contingent consideration and long-term debt, approximates their estimated fair values. The Company classifies all of its short-term and long-term investments in debt securities as available-for-sale. The fair value of contingent consideration was estimated using a discounted cash flow method.
Business Combinations and Valuation of Goodwill and Acquired Intangible Assets
The Company uses its best estimates and assumptions to allocate fair value to the net tangible and identifiable intangible assets acquired and liabilities assumed at the acquisition date. Any residual purchase price is recorded as goodwill. The Company’s estimates are inherently uncertain and subject to refinement and can include but are not limited to, the cash flows that an asset is expected to generate in the future, and the appropriate weighted-average cost of capital.
During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the acquisition date. The Company continues to collect information and reevaluates these estimates and assumptions quarterly and records any adjustments to the Company’s preliminary estimates to goodwill provided that the Company is within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s Condensed Consolidated Statement of Income and Comprehensive Income.
Recent Accounting Pronouncements
Recently Adopted Accounting Guidance
In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination as if it had originated the contracts. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted. We adopted the new standard effective January 1, 2023 and the guidance did not have a material impact on our consolidated financial statements.
3. Revenue
Disaggregation of Revenue
The following table depicts the disaggregation of revenue according to categories consistent with how the Company evaluates its financial performance and economic risk.
|
For the Three Months Ended |
|
|||||
|
2023 |
|
|
2022 |
|
||
North America |
$ |
37,760 |
|
|
$ |
43,587 |
|
International |
|
19,354 |
|
|
|
24,578 |
|
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
9
|
For the Three Months Ended |
|
|||||
|
2023 |
|
|
2022 |
|
||
Revenue under short-term contracts |
$ |
33,889 |
|
|
$ |
39,505 |
|
Revenue under longer-term contracts |
|
23,225 |
|
|
|
28,660 |
|
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
Contract Liabilities
Timing may differ between the satisfaction of performance obligations and the invoicing and collections of amounts related to the Company’s contracts with customers. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations. Additionally, certain customers may receive credits, which are accounted for as a material right. The Company estimates these amounts based on the expected amount of future services to be provided to the customer and allocates a portion of the transaction price to these material rights. The Company recognizes these material rights as the material rights are exercised. The resulting material rights amounts included in the contract liabilities on the accompanying Condensed Consolidated Balance Sheets was $1.5 million and $1.9 million at March 31, 2023, and December 31, 2022, respectively.
|
|
Contract Liabilities |
|
|
Year-to-Date Activity |
|
|
|
|
Balance at December 31, 2022 |
|
$ |
27,086 |
|
Billings |
|
|
52,378 |
|
Revenue Recognized |
|
|
(57,114 |
) |
Balance at March 31, 2023 |
|
$ |
22,350 |
|
The Company elected to apply the following practical expedients:
10
4. Fair Value Measurements
The Company measures certain financial assets and liabilities at fair value on a recurring basis, including short-term and long-term investments and contingent consideration. The Company’s bank and money market accounts are in bank deposits and are not quoted instruments. As such, the Company’s bank and money market accounts are all considered cash. The fair value of these financial assets and liabilities was determined based on three levels of input as follows:
The fair value hierarchy of the Company’s financial assets carried at fair value and measured on a recurring basis is as follows:
|
|
|
|
|
Fair Value Measurements at |
|
||||||||||
|
|
March 31, 2023 |
|
|
Quoted Prices |
|
|
Significant |
|
|
Significant |
|
||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Short-term investments (1) |
|
$ |
45,590 |
|
|
$ |
— |
|
|
$ |
45,590 |
|
|
$ |
— |
|
Total assets |
|
$ |
45,590 |
|
|
$ |
— |
|
|
$ |
45,590 |
|
|
$ |
— |
|
|
|
|
|
|
Fair Value Measurements at |
|
||||||||||
|
|
December 31, 2022 |
|
|
Quoted Prices |
|
|
Significant |
|
|
Significant |
|
||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Short-term investments (1) |
|
$ |
20,210 |
|
|
$ |
— |
|
|
$ |
20,210 |
|
|
$ |
— |
|
Total assets |
|
$ |
20,210 |
|
|
$ |
— |
|
|
$ |
20,210 |
|
|
$ |
— |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Contingent consideration - current (2) |
|
$ |
2,259 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,259 |
|
Total liabilities |
|
$ |
2,259 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,259 |
|
The following table provides a roll-forward of the fair value of the contingent consideration for the three months ended March 31, 2023:
|
|
Fair Value |
|
|
Year-to-Date Activity |
|
|
|
|
Balance at December 31, 2022 |
|
$ |
2,259 |
|
Payments on contingent liabilities |
|
|
(2,267 |
) |
Amortization of discount on contingent liabilities |
|
|
8 |
|
Balance at March 31, 2023 |
|
$ |
— |
|
11
As of March 31, 2023, the Company has no contingent consideration amounts remaining.
5. Cash, Cash Equivalents and Investments
Cash and cash equivalents are carried at cost, which approximates fair market value. As of March 31, 2023 and December 31, 2022, cash and cash equivalents totaled $307.1 million and $344.5 million respectively.
Investments are recorded at fair value with the related unrealized gains and losses included in accumulated other comprehensive income, a component of stockholders’ equity, net of tax. Realized gains and losses on the sale of these investments are determined using the specific identification method. There were no realized gains or losses as of March 31, 2023 or December 31, 2022.
Short-term investments consisted of the following:
|
|
March 31, 2023 |
|
|||||||||||||
|
|
Amortized |
|
|
Gross |
|
|
Gross |
|
|
Estimated |
|
||||
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Pooled bond funds |
|
$ |
45,812 |
|
|
$ |
— |
|
|
$ |
(222 |
) |
|
$ |
45,590 |
|
Total short-term investments |
|
$ |
45,812 |
|
|
$ |
— |
|
|
$ |
(222 |
) |
|
$ |
45,590 |
|
|
|
December 31, 2022 |
|
|||||||||||||
|
|
Amortized |
|
|
Gross |
|
|
Gross |
|
|
Estimated |
|
||||
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Pooled bond funds |
|
$ |
20,512 |
|
|
$ |
— |
|
|
$ |
(302 |
) |
|
$ |
20,210 |
|
Total short-term investments |
|
$ |
20,512 |
|
|
$ |
— |
|
|
$ |
(302 |
) |
|
$ |
20,210 |
|
6. Goodwill and Intangible Assets
Goodwill and indefinite-lived intangible assets are not amortized but are reviewed annually for impairment or more frequently if impairment indicators arise. The Company did not have any intangible assets with indefinite lives other than goodwill as of March 31, 2023 or December 31, 2022. There were no indications of impairment as of March 31, 2023, and the Company believes that, as of the balance sheet dates presented, none of the Company’s goodwill or intangible assets were impaired.
The following table summarizes the Company’s intangible assets, net:
|
|
|
|
March 31, 2023 |
|
|||||||||
|
|
Estimated |
|
Gross |
|
|
Accumulated |
|
|
Net |
|
|||
Customer relationships |
|
5-19 |
|
$ |
83,149 |
|
|
$ |
(17,725 |
) |
|
$ |
65,424 |
|
Developed websites, technology and patents |
|
10 |
|
|
32,376 |
|
|
|
(8,209 |
) |
|
|
24,167 |
|
Trademark, trade name and domain name |
|
5-16 |
|
|
7,491 |
|
|
|
(2,927 |
) |
|
|
4,564 |
|
Proprietary user information database and internet traffic |
|
5 |
|
|
1,093 |
|
|
|
(1,093 |
) |
|
|
— |
|
Non-compete agreements |
|
1.5-3 |
|
|
600 |
|
|
|
(369 |
) |
|
|
231 |
|
Total intangible assets |
|
|
|
$ |
124,709 |
|
|
$ |
(30,323 |
) |
|
$ |
94,386 |
|
12
|
|
|
|
December 31, 2022 |
|
|||||||||
|
|
Estimated |
|
Gross |
|
|
Accumulated |
|
|
Net |
|
|||
Customer relationships |
|
5-19 |
|
$ |
82,558 |
|
|
$ |
(16,404 |
) |
|
$ |
66,154 |
|
Developed websites, technology and patents |
|
10 |
|
|
31,768 |
|
|
|
(7,294 |
) |
|
|
24,474 |
|
Trademark, trade name and domain name |
|
5-16 |
|
|
7,391 |
|
|
|
(2,770 |
) |
|
|
4,621 |
|
Proprietary user information database and internet traffic |
|
5 |
|
|
1,083 |
|
|
|
(1,083 |
) |
|
|
— |
|
Non-compete agreements |
|
1.5-3 |
|
|
600 |
|
|
|
(332 |
) |
|
|
268 |
|
Total intangible assets |
|
|
|
$ |
123,400 |
|
|
$ |
(27,883 |
) |
|
$ |
95,517 |
|
Intangible assets are amortized over their estimated useful lives, which range from eighteen months to nineteen years, using methods of amortization that are expected to reflect the estimated pattern of economic use. The remaining amortization expense will be recognized over a weighted-average period of approximately 6.7 years. Amortization expense was $2.2 million and $2.3 million for the three months ended March 31, 2023 and 2022, respectively. Amortization expense relating to developed websites, technology and patents is recorded within costs of revenues. All other amortization is recorded within operating expenses as the remaining intangible assets consist of customer-related assets which generate website traffic that the Company considers to be in support of selling and marketing activities. The Company did not write off any fully amortized intangible assets in the first three months of 2023.
The Company expects amortization expense of intangible assets to be as follows:
Years Ending December 31: |
|
Amortization |
|
|
2023 (April 1 – December 31) |
|
$ |
6,539 |
|
2024 |
|
|
8,696 |
|
2025 |
|
|
8,658 |
|
2026 |
|
|
8,604 |
|
2027 |
|
|
8,599 |
|
Thereafter |
|
|
53,290 |
|
Total |
|
$ |
94,386 |
|
13
7. Net Income Per Common Share
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:
|
|
For the Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2023 |
|
|
2022 |
|
||
Numerator: |
|
|
|
|
|
|
||
Net income |
|
$ |
1,645 |
|
|
$ |
7,164 |
|
Denominator: |
|
|
|
|
|
|
||
Basic: |
|
|
|
|
|
|
||
Weighted average shares of common stock and vested, undelivered restricted stock units outstanding |
|
|
28,757,259 |
|
|
|
29,708,233 |
|
Diluted: |
|
|
|
|
|
|
||
Weighted average shares of common stock and vested, undelivered restricted stock units outstanding |
|
|
28,757,259 |
|
|
|
29,708,233 |
|
Effect of potentially dilutive shares (1) |
|
|
195,847 |
|
|
|
4,706,024 |
|
Total weighted average shares of common stock and vested, undelivered restricted stock units outstanding and potentially dilutive shares |
|
|
28,953,106 |
|
|
|
34,414,257 |
|
Net Income Per Common Share: |
|
|
|
|
|
|
||
Basic: |
|
|
|
|
|
|
||
Net income applicable to common stockholders |
|
$ |
1,645 |
|
|
$ |
7,164 |
|
Weighted average shares of stock outstanding |
|
|
28,757,259 |
|
|
|
29,708,233 |
|
Basic net income per common share |
|
$ |
0.06 |
|
|
$ |
0.24 |
|
Diluted: |
|
|
|
|
|
|
||
Net income applicable to common stockholders |
|
$ |
1,645 |
|
|
$ |
7,804 |
|
Weighted average shares of stock outstanding |
|
|
28,953,106 |
|
|
|
34,414,257 |
|
Diluted net income per common share (1) |
|
$ |
0.06 |
|
|
$ |
0.23 |
|
8. Convertible Notes and Loan Agreement
Convertible Notes
In December 2020, the Company issued $201.3 million in aggregate principal amount of 0.125% convertible senior notes due December 15, 2025 (the “2025 Notes”) and in December 2021, the Company issued $414 million in aggregate principal amount of 0.0% convertible senior notes due December 15, 2026 (the “2026 Notes”). At the time of the issuance of the 2026 Notes, a portion of the outstanding 2025 Notes were exchanged for shares of common stock and cash. As of March 31, 2023, approximately $51 million aggregate principal amount of the 2025 Notes remain outstanding. Further details are included below:
14
Issuance |
Maturity Date |
Interest Rate |
First Interest Payment Date |
Effective Interest Rate |
Semi-Annual Interest Payment Dates |
Initial Conversion Rate per $1,000 Principal |
Initial Conversion Price |
|
Number of Shares (in millions) |
|
2025 Notes |
December 15, 2025 |
0.125% |
June 15, 2021 |
0.8% |
June 15, and December 15 |
14.1977 |
$ |
70.43 |
|
1.0 |
2026 Notes |
December 15, 2026 |
0.0% |
–– |
0.0% |
–– |
7.6043 |
$ |
131.50 |
|
4.3 |
Each of the 2025 Notes and the 2026 Notes (collectively, the “Notes”) is governed by an indenture between the Company, as issuer, and U.S. Bank, National Association, as trustee (together the “Indentures”, and each such indenture, an “Indenture”). The Notes are unsecured and rank senior in right of payment to the Company’s future indebtedness that is expressly subordinated in right of payment to the Notes and equal in right of payment to the Company’s unsecured indebtedness that is not so subordinated.
Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of common stock, at the Company’s election.
Terms of the Notes
Prior to the close of business on September 15, 2025 and September 14, 2026, the 2025 Notes and 2026 Notes, respectively, will be convertible at the option of holders during certain periods, only upon satisfaction of certain conditions set forth below. On or after September 15, 2025 (for the 2025 Notes) and September 14, 2026 (for the 2026 Notes), until the close of business on the second scheduled trading day immediately preceding the applicable maturity date, holders may convert all or any portion of their Notes at the applicable conversion price at any time regardless of whether the conditions set forth below have been met.
Holders may convert all or a portion of their Notes prior to the close of business on the day immediately preceding their respective free convertibility date described above, in multiples of the $1,000 principal amount, only under the following circumstances:
As of March 31, 2023, the 2026 Notes and 2025 Notes are not convertible.
Whether the 2026 Notes or the 2025 Notes will be convertible in the future prior to the applicable free convertibility date will depend on the satisfaction of the trading price condition or another conversion condition specified in the Indentures. Since the Company may elect to repay the 2026 Notes and the 2025 Notes in cash, shares of our common stock, or a combination of both, the Company has continued to classify the 2026 and the 2025 Notes as long-term debt on its consolidated balance sheet as of March 31, 2023.
The Notes consist of the following:
|
March 31, 2023 |
|
|
December 31, 2022 |
|
||||||||||
Liability Component: |
2026 Notes |
|
|
2025 Notes |
|
|
2026 Notes |
|
|
2025 Notes |
|
||||
Principal |
$ |
414,000 |
|
|
$ |
51,381 |
|
|
$ |
414,000 |
|
|
$ |
51,381 |
|
Less: unamortized debt issuance costs |
|
8,131 |
|
|
|
929 |
|
|
|
8,673 |
|
|
|
1,014 |
|
Net carrying amount |
$ |
405,869 |
|
|
$ |
50,452 |
|
|
$ |
405,327 |
|
|
$ |
50,367 |
|
15
The following table sets forth total interest expense recognized related to the Notes:
|
March 31, 2023 |
|
|
March 31, 2022 |
|
||
0.125% Coupon |
$ |
16 |
|
|
$ |
16 |
|
Amortization of debt discount and transaction costs |
|
627 |
|
|
|
624 |
|
|
$ |
643 |
|
|
$ |
640 |
|
The fair value of the Notes, which was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, quoted prices of the Notes in an over-the-counter market (Level 2), and carrying value of debt instruments (carrying value excludes the equity component of the Company’s convertible notes classified in equity) were as follows:
|
March 31, 2023 |
|
|
December 31, 2022 |
|
||||||||||
|
Fair Value |
|
|
Carrying Value |
|
|
Fair Value |
|
|
Carrying Value |
|
||||
Convertible senior notes |
$ |
367,181 |
|
|
$ |
456,321 |
|
|
$ |
361,658 |
|
|
$ |
455,694 |
|
2021 Loan Agreement
On October 29, 2021, the Company entered into a Loan and Security Agreement with Western Alliance Bank, as administrative agent and collateral agent for the lenders, and the banks and other financial institutions or entities from time to time party thereto as lenders (the “2021 Loan Agreement”). The 2021 Loan Agreement provides for a $75 million revolving credit facility with a $5 million letter-of-credit sublimit and matures on October 29, 2023. The 2021 Loan Agreement is secured by substantially all of the Company’s assets. Borrowings under the 2021 Loan Agreement bear interest at a rate equal to one (1) month U.S. LIBOR, plus a spread based upon the Company’s leverage (as defined by 2021 Loan Agreement), which may vary between 2.00% and 2.75%. As of March 31, 2023, the interest rate was 7.42%. The 2021 Loan Agreement is subject to various leverage and non-financial covenants. No amounts were outstanding under the 2021 Loan Agreement as of March 31, 2023.
9. Leases and Contingencies
The Company conducts its operations in leased office facilities under various noncancelable operating lease agreements that expire through December 2029.
On October 26, 2017, the Company entered into a Third Amendment (the “Third Amendment”) to the lease agreement for office space in Newton, Massachusetts, dated as of August 4, 2009 (the “Newton Lease”). The Third Amendment extended the lease term to December 31, 2029 and preserves the Company’s option to extend the term for an additional five-year period subject to certain terms and conditions set forth in the Newton Lease. The Third Amendment reduced the rentable space from approximately 110,000 square feet to approximately 74,000 square feet effective January 1, 2018. As of January 1, 2018, base monthly rent under the Third Amendment is $0.3 million. The base rent increases biennially at a rate averaging approximately 1% per year, as of January 1, 2022. The Company remains responsible for certain other costs under the Third Amendment, including operating expense and taxes.
In April 2021, the Company entered into a Fourth Amendment (the “Fourth Amendment”). The Fourth Amendment became effective during May 2021. The Fourth Amendment reduced the rentable space from approximately 74,000 square feet to approximately 68,000 square feet and provided the Company with a one-time payment of approximately $0.6 million. As of May 1, 2021, base monthly rent is approximately $0.3 million per month. All other terms and conditions are substantially similar to those terms in the Third Amendment.
Certain of the Company’s operating leases, including the Newton Lease, include lease incentives and escalating payment amounts and are renewable for varying periods. The Company recognizes the related rent expense on a straight-line basis over the term of each lease, taking into account the lease incentives and escalating lease payments.
The Company has various non-cancelable lease agreements for certain of its offices with original lease periods expiring between 2023 and 2029. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain it will exercise that option. Leases with renewal options allow the Company to extend the lease term typically between 1 and 5 years. When determining the lease term, renewal options reasonably certain of being exercised are included in the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several economic factors, including but not limited to,
16
the significance of leasehold improvements incurred on the property, whether the asset is difficult to replace, underlying contractual obligations, or specific characteristics unique to that particular lease that would make it reasonably certain that the Company would exercise such option. Renewal and termination options were generally not included in the lease term for the Company's existing operating leases. Certain of the arrangements have discounted rent periods or escalating rent payment provisions. Leases with an initial term of twelve months or less are not recorded on the condensed consolidated balance sheets. The Company recognizes rent expense on a straight-line basis over the lease term.
As of March 31, 2023, operating lease assets were $19.5 million and operating lease liabilities were $23.5 million. The maturities of the Company’s operating lease liabilities as of March 31, 2023 were as follows:
|
|
Minimum Lease |
|
|
Years Ending December 31: |
|
Payments |
|
|
2023 (April 1 – December 31) |
|
$ |
3,674 |
|
2023 |
|
|
4,981 |
|
2024 |
|
|
4,061 |
|
2025 |
|
|
3,894 |
|
2026 |
|
|
3,349 |
|
Thereafter |
|
|
6,735 |
|
Total future minimum lease payments |
|
|
26,694 |
|
Less imputed interest |
|
|
3,189 |
|
Total operating lease liabilities |
|
$ |
23,505 |
|
Included in the Consolidated Balance Sheet: |
|
|
|
|
Current operating lease liability |
|
$ |
3,896 |
|
Non-current operating lease liability |
|
|
19,609 |
|
Total operating lease liabilities |
|
$ |
23,505 |
|
For the three months ended March 31, 2023 and 2022, the total lease cost was comprised of the following amounts:
|
|
Three Months Ended |
|
||||
|
|
2023 |
|
2022 |
|
||
Operating lease expense |
|
$ |
1,056 |
|
$ |
1,141 |
|
Short-term lease expense |
|
|
4 |
|
|
9 |
|
Total lease expense |
|
$ |
1,060 |
|
$ |
1,150 |
|
The following summarizes additional information related to operating leases:
|
|
As of |
|
|
|
|
March 31, 2023 |
|
|
Weighted-average remaining lease term — operating leases |
|
|
3.6 |
|
Weighted-average discount rate — operating leases |
|
|
3.7 |
% |
If the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rate as the discount rate. The Company uses its best judgment when determining the incremental borrowing rate, which is the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term to the lease payments in a similar currency.
Litigation
From time to time and in the ordinary course of business, the Company may be subject to various claims, charges, and litigation. At March 31, 2023 and December 31, 2022, the Company did not have any pending claims, charges, or litigation that it expects would have a material adverse effect on its condensed consolidated financial position, results of operations, or cash flows.
17
10. Stock-Based Compensation
Stock Option and Incentive Plans
In April 2007, the Company’s board of directors approved the 2007 Stock Option and Incentive Plan (the “2007 Plan”), which was approved by the stockholders of the Company and became effective upon the consummation of the Company’s IPO in May 2007. The 2007 Plan allowed the Company to grant incentive stock options (“ISOs”), non-qualified stock options (“NSOs”), stock appreciation rights, deferred stock awards, restricted stock units and other awards. Under the 2007 Plan, stock options could not be granted at less than fair market value on the date of grant and grants generally vested over a - to four-year period. Stock options granted under the 2007 Plan expire no later than ten years after the grant date. Additionally, beginning with awards made in August 2015, the Company had the option to direct a net issuance of shares for satisfaction of tax liability with respect to vesting of awards and delivery of shares. Prior to August 2015, this choice of settlement method was solely at the discretion of the award recipient. The 2007 Plan expired in May 2017.
No new awards may be granted under the 2007 Plan; however, the shares of common stock remaining in the 2007 Plan are available for issuance in connection with previously awarded grants under the 2007 Plan. There are 22,500 shares of common stock that remain subject to outstanding stock grants under the 2007 Plan as of March 31, 2023.
In March 2017, the Company’s board of directors approved the 2017 Stock Option and Incentive Plan (the “2017 Plan”), which was approved by the stockholders of the Company at the 2017 Annual Meeting and became effective June 16, 2017. The 2017 Plan replaces the Company’s 2007 Plan. On June 16, 2017, 3,000,000 shares of the Company’s common stock were reserved for issuance under the 2017 Plan and, generally, shares that are forfeited or canceled from awards under the 2017 Plan also will be available for future awards. In April 2021, the stockholders of the Company authorized the issuance of up to an additional 3,800,000 shares of the Company’s common stock under the 2017 Plan. Under the 2017 Plan, the Company may grant restricted stock and restricted stock units, non-qualified stock options, stock appreciation rights, performance awards, and other stock-based and cash-based awards. Grants generally vest in equal tranches over a three-year period. Stock options granted under the 2017 Plan expire no later than ten years after the grant date. Shares of stock issued pursuant to restricted stock awards are restricted in that they are not transferable until they vest. Shares of stock underlying awards of restricted stock units are not issued until the units vest. Non-qualified stock options cannot be exercised until they vest. Under the 2017 Plan, all stock options and stock appreciation rights must be granted with an exercise price that is at least equal to the fair market value of the common stock on the date of grant. The 2017 Plan broadly prohibits the repricing of options and stock appreciation rights without stockholder approval and requires that no dividends or dividend equivalents be paid with respect to options or stock appreciation rights. The 2017 Plan further provides that, in the event any dividends or dividend equivalents are declared with respect to restricted stock, restricted stock units, other stock-based awards and performance awards (referred to as “full-value awards”), such dividends or dividend equivalents would be subject to the same vesting and forfeiture provisions as the underlying award. There are a total of 1,852,898 shares of common stock that remain subject to outstanding stock-based grants under the 2017 Plan as of March 31, 2023. A total of 2,139,465 shares of common stock remain available for issuance under the 2017 Plan as of March 31, 2023.
Employee Stock Purchase Plan
In April 2022, the Company’s board of directors approved the TechTarget, Inc. 2022 Employee Stock Purchase Plan (the “ESPP”), which was approved by the stockholders of the Company at the 2022 Annual Meeting of Stockholders and became effective June 7, 2022. On June 7, 2022, 600,000 shares of the Company’s common stock were reserved for issuance under the ESPP. After the initial offering period of three months, commencing September 1, 2022, eligible employees will be offered shares of common stock over a twelve-month offering period, which consists of two consecutive six-month purchase periods. Employees may purchase a limited amount (up to $25,000) of shares of the Company’s common stock under the ESPP at a discount of up to 15% of the lesser of the market value of the common stock at either (a) the beginning of the six-month purchase period during which the shares of common stock are purchased or (b) the end of such six-month purchase period. As of March 31, 2023, 590,857 shares of common stock remain available for issuance under the ESPP.
Accounting for Stock-Based Compensation
The Company uses the Black-Scholes option pricing model to calculate the grant date fair value of an award.
The expected volatility of options granted has been determined using a weighted average of the historical volatility of the Company’s common stock for a period equal to the expected life of the option. The expected life of options has been determined utilizing
18
the “simplified” method. The risk-free interest rate is based on a zero coupon U.S. treasury instrument whose term is consistent with the expected life of the stock options. The Company has not paid and does not anticipate paying cash dividends on its shares of common stock; therefore, the expected dividend yield is assumed to be zero. The Company applied an estimated annual forfeiture rate based on historical averages in determining the expense recorded in each period.
A summary of the stock option activity under the Company’s plans for the three months ended March 31, 2023 is presented below:
Three Month Activity |
|
Options |
|
|
Weighted- |
|
|
Weighted- |
|
|
Aggregate |
|
||||
Options outstanding at December 31, 2022 |
|
|
120,000 |
|
|
$ |
37.29 |
|
|
|
— |
|
|
|
— |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Exercised |
|
|
(2,500 |
) |
|
$ |
7.03 |
|
|
|
— |
|
|
$ |
81 |
|
Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cancelled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Options outstanding at March 31, 2023 |
|
|
117,500 |
|
|
$ |
37.94 |
|
|
|
6.31 |
|
|
$ |
1,271 |
|
Options exercisable at March 31, 2023 |
|
|
97,500 |
|
|
$ |
30.74 |
|
|
|
5.72 |
|
|
$ |
1,271 |
|
Options vested or expected to vest at March 31, 2023 |
|
|
117,180 |
|
|
$ |
37.84 |
|
|
|
6.30 |
|
|
$ |
1,271 |
|
(1) The aggregate intrinsic value was calculated based on the positive difference between the fair value of the Company’s common stock on March 31, 2023 of $36.12 per share and the exercise price of the underlying options. The total intrinsic value of options exercised was $81 thousand and $0 thousand during the three months ended March 31, 2023 and March 31, 2022, respectively.
The total amount of cash received from exercise of these options was approximately $18 thousand and $0 during the three months ended March 31, 2023 and March 31, 2022, respectively.
Restricted Stock Units
Restricted stock units are valued at the market price of a share of the Company’s common stock on the date of the grant. A summary of the restricted stock unit activity under the Company’s plans for the three months ended March 31, 2023 is presented below:
Year-to-Date Activity |
|
Shares |
|
|
Weighted- |
|
|
Aggregate |
|
|||
Nonvested outstanding at December 31, 2022 |
|
|
1,642,799 |
|
|
$ |
62.40 |
|
|
|
— |
|
Granted |
|
|
194,856 |
|
|
|
43.08 |
|
|
|
— |
|
Vested |
|
|
(68,357 |
) |
|
|
63.55 |
|
|
|
— |
|
Forfeited |
|
|
(11,400 |
) |
|
|
66.12 |
|
|
|
— |
|
Nonvested outstanding at March 31, 2023 |
|
|
1,757,898 |
|
|
$ |
60.19 |
|
|
$ |
63,495 |
|
There were 68,357 restricted stock units with a total grant-date fair value of $4.3 million that vested during the three months ended March 31, 2023. There were 146,933 restricted stock units with a total grant-date fair value of $11.2 million that vested during the three months ended March 31, 2022.
As of March 31, 2023, there was $77.7 million of total unrecognized compensation expense related to stock options and restricted stock units, which is expected to be recognized over a weighted average period of 1.8 years.
19
Employee Stock Purchase Plan
The initial offering period under the ESPP began September 1, 2022 and ran through November 30, 2022.
For the three months ended March 31, 2023 and 2022, no shares were issued under this plan.
Valuation Assumptions
The valuation of ESPP purchase rights and the underlying weighted-average assumptions are summarized as follows:
|
|
March 31, 2023 |
|
|
ESPP: |
|
|
|
|
Expected term in years |
|
|
0.50 |
|
Risk-free interest rate |
|
|
4.61 |
% |
Expected volatility |
|
|
47 |
% |
Expected dividend yield |
|
|
— |
% |
Weighted-average fair value per right granted |
|
$ |
13.47 |
|
11. Stockholders’ Equity
Common Stock Repurchase Programs
In May 2020, the Company announced that its board of directors had authorized a $25.0 million stock repurchase program (the “May 2020 Repurchase Program”) whereby the Company was authorized to repurchase shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management. The Company repurchased 4,614 shares at an aggregate purchase price of $0.3 million and an average share price of $69.91 under this plan for the three months ended March 31, 2022. The May 2020 Repurchase Program expired on May 1, 2022, with $10.8 million in authorized remaining capacity.
In May 2022, the Company announced that its board of directors had authorized a stock repurchase program (the “May 2022 Repurchase Program”) whereby the Company was authorized to repurchase shares of the Company’s common stock having an aggregate purchase prices of up to $50.0 million from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management. During the three months ended March 31, 2022, there were no amounts purchased under the May 2022 Repurchase Program. As of March 31, 2023, no amounts remained available under the May 2022 Repurchase Program.
In November 2022, the Company announced that its board of directors had authorized a repurchase program (the “November 2022 Repurchase Program”) whereby the Company was authorized to repurchase shares of the Company’s common stock and Notes having an aggregate purchase price of up to $200.0 million from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management over the next two years. During the three month period ended March 31, 2023, the Company repurchased 581,295 shares for an aggregate purchase price of $25.0 million at an average share price of $42.99 under the November 2022 Repurchase Program. As of March 31, 2023, $160.1 million remained available under the November 2022 Repurchase Program.
Repurchased shares are recorded under the cost method and are reflected as treasury stock in the accompanying Condensed Consolidated Balance Sheets.
Reserved Common Stock
As of March 31, 2023, the Company has reserved (i) 4,014,863 shares of common stock for settlement of outstanding and unexercised options, issuance following vesting of outstanding restricted stock units, and future awards available for grant under the 2007 Plan and 2017 Plan, (ii) 590,857 shares of common stock for use in settling purchases under the ESPP and (iii) 5,349,987 shares which may be issuable upon conversion of the Notes.
20
12. Income Taxes
The Company measures its interim period tax expense using an estimated annual effective tax rate and adjustments for discrete taxable events that occur during the interim period. The estimated annual effective income tax rate is based upon the Company’s estimations of annual pre-tax income, the geographic mix of pre-tax income, and its interpretations of tax laws. The Company updates the estimate of its annual effective tax rate at the end of each quarterly period. The Company recorded income tax expense of $1.4 million and $2.9 million for the three months ended March 31, 2023 and 2022, respectively. The tax expense for the three months ended March 31, 2023 decreased by approximately $1.5 million, as compared to the same period in 2022, primarily due to a decrease in pretax income that resulted in a $2.2 million decrease in tax expenses based on the Company's projected effective tax rate and offset by an approximate $0.6 million increase in stock compensation shortfalls.
13. Segment Information
The Company views its operations and manages its business as one operating segment which is the business of providing purchase intent marketing and sales services. The Company aggregated its operating segment based upon the similar economic and operating characteristics of its operations.
Geographic Data
Net sales by campaign target area were as follows (1):
|
For the Three Months Ended |
|
|||||
|
2023 |
|
|
2022 |
|
||
North America |
$ |
37,760 |
|
|
$ |
43,587 |
|
International |
|
19,354 |
|
|
|
24,578 |
|
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
Net sales to unaffiliated customers by geographic area were as follows (2):
|
For the Three Months Ended |
|
|||||
|
2023 |
|
|
2022 |
|
||
United States |
$ |
43,674 |
|
|
$ |
50,739 |
|
United Kingdom |
|
6,068 |
|
|
|
7,663 |
|
Other international |
|
7,372 |
|
|
|
9,763 |
|
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
Long-lived assets by geographic area were as follows:
|
|
March 31, 2023 |
|
|
December 31, 2022 |
|
||
United States |
|
$ |
222,586 |
|
|
$ |
222,488 |
|
International |
|
|
88,080 |
|
|
|
87,763 |
|
Total |
|
$ |
310,666 |
|
|
$ |
310,251 |
|
Long-lived assets are comprised of property and equipment, net; goodwill; and intangible assets, net. The United Kingdom accounted for 28% of the Company’s long-lived assets for the three months ended March 31, 2023 and no single country outside of the U.S. or United Kingdom accounted for 1% or more of the Company’s long-lived assets during either of these periods.
21
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors including those discussed below in this Quarterly Report on Form 10-Q, in our Annual Report on Form 10-K for the year ended December 31, 2022 under Part I, Item 1A, “Risk Factors,” and in the other documents we file with the Securities and Exchange Commission. Please refer to our cautionary note regarding “Forward-Looking Statements” section on page 32 of this Quarterly Report on Form 10-Q.
Overview
TechTarget, Inc. (the “Company”, “we”, “us” or “our”) is a global data, software and analytics leader for purchase intent-driven marketing and sales data which delivers business impact for business-to-business (“B2B”) companies. Our solutions are designed to enable B2B technology companies to identify, reach, and influence key enterprise technology decision makers faster and with higher efficacy. We offer products and services intended to improve information technology (“IT”) vendors’ abilities to impact highly targeted audiences for business growth using advanced targeting, first-party analytics and data services complemented with customized marketing programs that integrate content creation, demand generation, brand marketing, and other advertising techniques.
Our goal is to enable enterprise technology and business professionals to navigate the complex and rapidly-changing enterprise technology landscape where purchasing decisions can have significant financial and operational consequences. Our content strategy includes three primary sources that enterprise technology and business professionals use to assist them in their pre-purchase research: independent content provided by our professionals, vendor-generated content provided by our customers and member-generated or peer-to-peer content. In addition to utilizing our independent editorial content, registered members and users appreciate the ability to deepen their pre-purchase research by accessing the extensive vendor-supplied content we make available across our virtual events, webinar channels and website network (collectively, our “Network”). Likewise, these members and users can derive significant additional value from the ability to seamlessly interact with and contribute to information exchanges in a given field on our Network. To advance our ability to provide purchase intent-driven marketing and sales data, we have been acquisitive over the last three years. During 2021, we acquired Xtelligent Healthcare Media, LLC, a leading healthcare B2B media company focusing on healthcare-related technology. Similarly, during 2020, we acquired (i) BrightTALK Limited, a technology media company that provides customers with a platform to create, host and promote webinar and video content, (ii) The Enterprise Strategy Group, Inc., a leading provider of decision support content based on user research and market analysis for global enterprise companies, and (iii) Data Science Central, LLC, a digital publishing and media company focused on data science and business analytics.
We had approximately 30.7 million and 29.4 million registered members and users, which we refer to as our “audiences”, as of March 31, 2023 and 2022, respectively. While the size of our audiences does not provide direct insight into our customer numbers or our revenue, we believe the value of the services we sell to our customers is a direct result of the breadth and reach of this content footprint. This footprint creates the opportunity for our clients to gain business leverage by targeting our audiences through customized marketing programs. Likewise, the behavior exhibited by these audiences enables us to provide our customers with data products designed to improve their marketing and sales efforts. The targeted nature of our audiences enables B2B technology companies to reach a specialized audience efficiently because our content is highly segmented and aligned with the B2B technology companies’ specific products.
Through our ability to identify, reach and influence key decision makers, we have developed a broad customer base and, in 2023 expect to deliver marketing and sales services programs to over 3,000 customers.
Executive Summary
Financial Results For the Three Months Ended March 31, 2023
Our revenue for the three months ended March 31, 2023 decreased by $11.1 million, or 16%, to $57.1 million, compared with $68.2 million, during the same period in 2022. We saw decreased customer spend across our product suite. The amount of revenue that we derived from longer-term contracts, which we define as contracts with a term of in excess of 270 days, in the first quarter of 2023 decreased 19%, compared to the first quarter of 2022.
Our international geo-targeted revenue, where our target audience is outside North America (“International”), decreased approximately 21% for the three months ended March 31, 2023, compared with the prior year period driven by the items noted above.
22
Gross profit percentage was 68% and 73% for the three months ended March 31, 2023 and 2022, respectively. Gross profit decreased by $10.5 million, mainly due to the decrease in revenue compared to the same period a year ago.
Business Trends
The following discussion highlights key trends affecting our business.
Our key strategic initiatives include:
Our revenue was down 16% for the three months ended March 31, 2023 compared to the same period in the prior year, which was primarily driven by the factors noted above.
Sources of revenues
Revenue changes for the three month periods ended March 31, 2023, as compared to the same periods in 2022, are shown in the table below. See the discussion above and Notes 3 and 13 to our condensed consolidated financial statements for additional information on our revenues.
|
For the Three Months Ended |
|
|
|||||
(dollars in thousands) |
2023 |
|
|
2022 |
|
|
||
North America |
$ |
37,760 |
|
|
$ |
43,587 |
|
-13% |
International |
|
19,354 |
|
|
|
24,578 |
|
-21% |
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
-16% |
23
|
For the Three Months Ended |
|
|||||
(dollars in thousands) |
2023 |
|
|
2022 |
|
||
Revenue under short-term contracts |
$ |
33,889 |
|
|
$ |
39,505 |
|
Revenue under longer-term contracts |
|
23,225 |
|
|
|
28,660 |
|
Total |
$ |
57,114 |
|
|
$ |
68,165 |
|
We sell customized marketing programs to B2B technology companies targeting a specific audience within a particular enterprise technology or business sector or sub-sector. We maintain multiple points of contact with our customers to provide support throughout their organizations and their customers’ IT sales cycles. As a result, our customers often run multiple advertising programs with us in order to target their desired audience of enterprise technology and business professionals more effectively. There are multiple factors that can impact our customers’ marketing and advertising objectives and spending with us, including but not limited to, IT product launches, increases or decreases to their advertising budgets, the timing of key industry marketing events, responses to competitor activities and efforts to address specific marketing objectives such as creating brand awareness or generating sales leads. Our products and services are generally delivered under short-term contracts that run for the length of a given program, typically less than nine months. In the quarter ended March 31, 2023 approximately 41% of our revenues were from longer-term contracts.
Product and Service Offerings
We use our offerings to provide B2B technology companies with numerous touch points to identify, reach and influence key enterprise technology decision makers. The following is a description of the products and services we offer:
24
Cost of Revenue, Operating Expenses, and Other
Expenses consist of cost of revenue, selling and marketing, product development, general and administrative, depreciation and amortization, and interest and other expense, net. Personnel-related costs are a significant component of each of these expense categories except for depreciation and amortization and interest and other expense, net.
Cost of Revenue. Cost of revenue consists primarily of salaries and related personnel costs; member acquisition expenses (primarily keyword purchases from leading internet search sites); lead generation expenses; freelance writer expenses; website hosting costs; vendor expenses associated with the delivery of webcast, podcast, videocast and similar content and other offerings; stock-based compensation expenses; facility expenses and other related overhead.
Selling and Marketing. Selling and marketing expenses consist primarily of: salaries and related personnel costs; sales commissions; travel-related expenses; stock-based compensation expenses; facility expenses and other related overhead. Sales commissions are recorded as expense when earned by the employee.
Product Development. Product development includes the creation and maintenance of our network of websites, advertiser offerings and technical infrastructure. Product development expense consists primarily of salaries and related personnel costs; stock-based compensation expenses; facility expenses, and other related overhead.
General and Administrative. General and administrative expenses consist primarily of salaries and related personnel costs; facility expenses and related overhead; accounting, legal and other professional fees; and stock-based compensation expenses.
Depreciation. Depreciation expense consists of the depreciation of our property and equipment and other capitalized assets. Depreciation is calculated using the straight-line method over their estimated useful lives, ranging from three to ten years.
Amortization. Amortization expense consists of the amortization of intangible assets recorded in connection with our acquisitions, including changes in the value of contingent consideration in relation to certain of the acquisitions. Separable intangible assets that are not deemed to have an indefinite life are amortized over their estimated useful lives, which range from eighteen months to nineteen years, using methods that are expected to reflect the estimated pattern of economic use.
Interest and Other Expense, Net. Interest expense, net consists primarily of interest costs (offset by interest income), inducement expense and the related amortization of deferred issuance costs on our Notes and amounts borrowed under our current and our prior loan agreements and amortization of premiums on our investments, less any interest income earned on cash, cash equivalents and short-term investments. We historically have invested our cash in money market accounts, municipal bonds, government agency bonds, U.S. Treasury securities, and corporate bonds. Other expense, net consists primarily of non-operating gains or losses, primarily related to realized and unrealized foreign currency gains and losses on trade assets and liabilities.
Non-GAAP Financial Measure
We use Adjusted Revenue, a non-GAAP financial measure to assist us in evaluating our operating performance to understand and compare operating results across accounting periods, for internal budgeting and forecasting purposes, for short- and long-term operating plans, and to evaluate our financial performance. We believe that non-GAAP Adjusted Revenue reflects our ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in our business. We also believe that this
25
non-GAAP measure provides useful information to investors and others in understanding and evaluating our operating results and prospects in the same manner as management and in comparing financial results across accounting periods. Regulation S-K Item 10(e), “Use of non-GAAP financial measures in Commission filings,” defines and prescribes the conditions for use of non-GAAP financial information.
A limitation of our non-GAAP financial measure of Adjusted Revenue is that it does not have a uniform definition. Our definition will likely differ from the definitions used by other companies, and therefore comparability may be limited.
We compensate for these limitations by reconciling the non-GAAP financial measure to GAAP revenue, the most comparable GAAP financial measure. Adjusted Revenue should be considered in addition to, not as a substitute for or in isolation from, GAAP revenue. We encourage investors and others to review our financial information in its entirety, not to rely on any single financial measure, and to view our non-GAAP financial measure in conjunction with the most comparable GAAP financial measure.
Adjusted Revenue
We define Adjusted Revenue as the sum of revenue and the impact of fair value adjustments to acquired unearned revenue related to services billed by an acquired company prior to its acquisition. Management uses this measure to evaluate growth of the business period over period, excluding the impact of adjustments due to purchase accounting. We believe that it is important to evaluate growth on this basis. We expect our Adjusted Revenue to converge over time with our GAAP revenue.
The following table presents a reconciliation of Revenue to Adjusted Revenue:
|
|
Three Months Ended March 31, |
|
|||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
||
Revenue |
|
$ |
57,114 |
|
|
$ |
68,165 |
|
Impact of fair value adjustment on acquired unearned revenue |
|
|
— |
|
|
|
1,175 |
|
Adjusted Revenue |
|
$ |
57,114 |
|
|
$ |
69,340 |
|
Revenue percentage change |
|
|
-16 |
% |
|
|
|
|
Adjusted revenue percentage change |
|
|
-18 |
% |
|
|
|
Application of Critical Accounting Policies and Use of Estimates
The discussion of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates, judgments and assumptions that affect the reported amount of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue, long-lived assets, goodwill, allowance for doubtful accounts, stock-based compensation, contingent liabilities, self-insurance accruals and income taxes. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Our actual results may differ from these estimates under different assumptions or conditions.
Our critical accounting policies are those that affect our more significant judgments used in the preparation of our condensed consolidated financial statements. A description of our critical accounting policies and estimates is contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. Other than those noted in Note 2 to our condensed consolidated financial statements, there were no material changes to our critical accounting policies and estimates during the first three months of 2023.
Income Taxes
We are subject to income taxes in both the U.S. and foreign jurisdictions, and we use estimates in determining our provision for income taxes. We recognize deferred tax assets and liabilities based on temporary differences between the financial reporting and income tax bases of assets and liabilities using statutory rates expected to be in effect when such differences are settled.
Our net deferred tax liabilities are comprised primarily of book to tax differences on stock-based compensation, intangible asset basis, net operating loss carryforwards, valuation allowance and timing of deductions for right-of-use assets and lease liabilities, accrued expenses, depreciation, and amortization.
26
Results of Operations
The following table sets forth our results of operations for the periods indicated, including percentage of total revenue:
|
|
Three Months Ended March 31, |
|
|||||||||||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
||||||||||
Revenue |
|
$ |
57,114 |
|
|
|
100 |
% |
|
$ |
68,165 |
|
|
|
100 |
% |
Cost of revenue |
|
|
17,350 |
|
|
|
30 |
% |
|
|
17,846 |
|
|
|
26 |
% |
Amortization of acquired technology |
|
|
673 |
|
|
|
1 |
% |
|
|
745 |
|
|
|
1 |
% |
Gross profit |
|
|
39,091 |
|
|
|
68 |
% |
|
|
49,574 |
|
|
|
73 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling and marketing |
|
|
24,756 |
|
|
|
43 |
% |
|
|
24,255 |
|
|
|
35 |
% |
Product development |
|
|
2,609 |
|
|
|
5 |
% |
|
|
3,118 |
|
|
|
5 |
% |
General and administrative |
|
|
7,918 |
|
|
|
14 |
% |
|
|
7,842 |
|
|
|
12 |
% |
Depreciation |
|
|
2,000 |
|
|
|
4 |
% |
|
|
1,665 |
|
|
|
2 |
% |
Amortization |
|
|
1,493 |
|
|
|
3 |
% |
|
|
2,012 |
|
|
|
3 |
% |
Total operating expenses |
|
|
38,776 |
|
|
|
68 |
% |
|
|
38,892 |
|
|
|
57 |
% |
Operating income |
|
|
315 |
|
|
|
1 |
% |
|
|
10,682 |
|
|
|
16 |
% |
Interest and other income (expense), net |
|
|
2,757 |
|
|
|
5 |
% |
|
|
(560 |
) |
|
|
-1 |
% |
Income before provision for income taxes |
|
|
3,072 |
|
|
|
5 |
% |
|
|
10,122 |
|
|
|
15 |
% |
Provision for income taxes |
|
|
1,427 |
|
|
|
2 |
% |
|
|
2,958 |
|
|
|
4 |
% |
Net income |
|
$ |
1,645 |
|
|
|
3 |
% |
|
$ |
7,164 |
|
|
|
11 |
% |
Comparison of Three Months Ended March 31, 2023 and March 31, 2022
Revenue
|
|
Three Months Ended March 31, |
|
|||||||||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
Decrease |
|
Percent |
|
||||
Revenue |
|
$ |
57,114 |
|
|
$ |
68,165 |
|
$ |
(11,051 |
) |
|
-16 |
% |
Revenues for the three months ended March 31, 2023 decreased by $11.1 million, or 16%, over the three months ended March 31, 2022, primarily due to the following:
Cost of Revenue and Gross Profit
|
|
Three Months Ended March 31, |
|
|||||||||||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
|
Decrease |
|
|
Percent |
|
||||
Cost of revenue |
|
$ |
17,350 |
|
|
$ |
17,846 |
|
|
$ |
(496 |
) |
|
|
-3 |
% |
Amortization of acquired technology |
|
|
673 |
|
|
|
745 |
|
|
|
(72 |
) |
|
|
-10 |
% |
Total cost of revenue |
|
$ |
18,023 |
|
|
$ |
18,591 |
|
|
$ |
(568 |
) |
|
|
-3 |
% |
Gross profit |
|
$ |
39,091 |
|
|
$ |
49,574 |
|
|
$ |
(10,483 |
) |
|
|
-21 |
% |
Gross profit percentage |
|
|
68 |
% |
|
|
73 |
% |
|
|
|
|
|
|
27
Costs of Revenues. Costs of Revenues for the three months ended March 31, 2023 decreased by $0.6 million as compared to the three months ended March 31, 2022 primarily due to the following:
Gross Profit. Our gross profit is equal to the difference between our revenue and our cost of revenue for the period. Gross profit percentage was 68% and 73% for the three months ended March 31, 2023 and 2022, respectively. Gross profit decreased by $10.5 million in the three months ended March 31, 2023 compared to the same period in 2022, primarily due to decreased revenue compared to the same period a year ago. Because the majority of our costs are labor-related, we expect our gross profit to fluctuate from period to period depending on the total revenue for the period.
Operating Expenses and Other
|
|
Three Months Ended March 31, |
|
|||||||||||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
|
Increase |
|
|
Percent |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling and marketing |
|
$ |
24,756 |
|
|
$ |
24,255 |
|
|
$ |
501 |
|
|
|
2 |
% |
Product development |
|
|
2,609 |
|
|
|
3,118 |
|
|
|
(509 |
) |
|
|
-16 |
% |
General and administrative |
|
|
7,918 |
|
|
|
7,842 |
|
|
|
76 |
|
|
|
1 |
% |
Depreciation |
|
|
2,000 |
|
|
|
1,665 |
|
|
|
335 |
|
|
|
20 |
% |
Amortization |
|
|
1,493 |
|
|
|
2,012 |
|
|
|
(519 |
) |
|
|
-26 |
% |
Total operating expenses |
|
$ |
38,776 |
|
|
$ |
38,892 |
|
|
$ |
(116 |
) |
|
|
0 |
% |
Interest and other income (expense), net |
|
$ |
2,757 |
|
|
$ |
(560 |
) |
|
$ |
(3,317 |
) |
|
|
-592 |
% |
Provision for income taxes |
|
$ |
1,427 |
|
|
$ |
2,958 |
|
|
$ |
(1,531 |
) |
|
|
-52 |
% |
Selling and Marketing. Selling and marketing expenses increased for the three months ended March 31, 2023, as compared to the same period in 2022, primarily due to a $2.5 million increase in stock-based compensation expense offset by a $1.7 million decrease in pay related expenses.
Product Development. Product development expenses decreased for the three months ended March 31, 2023, as compared to the same period in 2022, primarily due to a $0.5 million decrease in pay related expenses.
General and Administrative. General and administrative expenses increased for the three months ended March 31, 2023, as compared to the same period in 2022, primarily due to a $0.2 million decrease in pay related expenses offset by increased other costs totaling $0.3 million.
Depreciation. Depreciation expense increased for the three months ended March 31, 2023, as compared to the same period in 2022, primarily due to increased capitalized software expenses.
Amortization. Amortization expense decreased for the three months ended March 31, 2023, as compared to the same period in 2022, due to a decrease in fair value of contingent consideration.
Interest and other expense. Interest and other expense decreased for the three months ended March 31, 2023, as compared to the same period in 2022, primarily due to a $3.2 million increase in interest income.
Provision for income taxes. Our effective income tax rate was 46% and 29% for the three months ended March 31, 2023 and 2022, respectively. The tax expense for the three months ended March 31, 2023 decreased by approximately $1.5 million primarily due to a decrease in pretax income that resulted in a $2.2 million decrease in tax expense based on our projected effective tax rate and offset by $0.6 million increase in stock compensation shortfalls.
28
Seasonality
The timing of our revenues is affected by seasonal factors. Our revenues are seasonal primarily as a result of the annual budget approval process of many of our customers, the normal timing at which our customers introduce new products, and the historical decrease in advertising in summer months. The timing of revenues in relation to our expenses, much of which do not vary directly with revenues, has an impact on our cost of revenues, selling and marketing, product development, and general and administrative expenses as a percentage of revenues in each calendar quarter during the year.
The majority of our expenses are personnel-related and include salaries, stock-based compensation, benefits and incentive-based compensation plan expenses. As a result, we have not experienced significant seasonal fluctuations in the timing of our expenses period to period.
Liquidity and Capital Resources
Resources
Our cash, cash equivalents and investments at March 31, 2023 totaled $352.7 million, a $12.1 million decrease from December 31, 2022, primarily driven by purchases of investments and repurchases under stock buyback programs offset by the cash generated from our operations. We believe that our existing cash, cash equivalents and investments, our cash flow from operating activities and available borrowings under our Loan and Security Agreement with Western Alliance Bank, as administrative agent and collateral agent for the lenders, and the banks and other financial institutions or entities from time to time party thereto as lenders (the “2021 Loan Agreement”) will be sufficient to meet our anticipated cash needs for at least the next twelve months. Our future working capital requirements will depend on many factors, including the operations of our existing business, our potential strategic expansion internationally, future acquisitions we might undertake and any expansion into complementary businesses. To the extent that our cash, cash equivalents and investments and cash flow from operating activities are insufficient to fund our future activities, we may raise additional funds through additional bank credit arrangements or public or private equity or debt financings. We may also raise additional funds in the event we determine in the future to effect one or more additional acquisitions of businesses.
(dollars in thousands) |
|
March 31, |
|
|
December 31, |
|
||
Cash, cash equivalents and investments |
|
$ |
352,679 |
|
|
$ |
364,733 |
|
Accounts receivable, net |
|
$ |
51,375 |
|
|
$ |
60,359 |
|
Cash, Cash Equivalents and Investments
Our cash, cash equivalents and investments at March 31, 2023 were held for working capital purposes and were invested primarily in government backed money market funds and pooled bond funds. We do not enter into investments for trading or speculative purposes.
Accounts Receivable, Net
Our accounts receivable balance fluctuates from period to period, which affects our cash flows from operating activities. The fluctuations vary depending on the timing with which we meet our performance obligations and on the timing of our cash collections, as well as on changes to our allowance for doubtful accounts. We use days sales outstanding (“DSO”) as a measurement of the quality and status of our receivables since lower DSO is generally correlated with higher collection rates. We define DSO as net accounts receivable at quarter end divided by total revenue for the applicable period, multiplied by the number of days in the applicable period. DSO was 80 days and 76 days at March 31, 2023 and December 31, 2022, respectively.
29
Cash Flows
|
|
Three Months Ended March 31, |
|
|||||
(dollars in thousands) |
|
2023 |
|
|
2022 |
|
||
Net cash provided by operating activities |
|
$ |
18,218 |
|
|
$ |
27,557 |
|
Net cash used in investing activities |
|
$ |
(28,847 |
) |
|
$ |
(3,611 |
) |
Net cash used in financing activities |
|
$ |
(27,426 |
) |
|
$ |
(9,911 |
) |
Operating Activities
Cash provided by operating activities primarily consists of net income adjusted for certain non-cash items including depreciation and amortization, provisions for bad debt, stock-based compensation, deferred income taxes, and the effect of changes in working capital and other activities. Cash provided by operating activities for the three months ended March 31, 2023 was $18.2 million compared to cash provided by operating activities of $27.6 million for the three months ended March 31, 2022.
The decrease in cash provided by operating activities was primarily the result of decrease in revenue, changes in working capital and stock-based compensation charged to earnings.
Investing Activities
Cash used in investing activities in the three months ended 2023 and 2022 was $28.8 million and $3.6 million respectively and was driven by the purchases of investments and the purchase of property and equipment, primarily for internal-use software, and to a lesser extent, computer equipment. We capitalized internal-use software and website development costs of $3.4 million and $3.2 million for the three months ended March 31, 2023 and 2022, respectively.
Financing Activities
In the first three months of 2023, we used $27.4 million for financing activities, consisting primarily of $2.3 million for the payment of contingent consideration related to our 2021 acquisitions, $0.2 million for tax withholdings related to net share settlements and $25.0 million for the repurchase of TechTarget shares. In the first three months of 2022, we used $9.9 million for financing activities, consisting primarily of $5.2 million for the payment of contingent consideration related to our 2020 and 2021 acquisitions, $4.4 million for tax withholdings related to net share settlements and $0.3 million for the repurchase of TechTarget shares.
Common Stock Repurchase Programs
In May 2020, we announced that our board of directors had authorized a $25.0 million stock repurchase program (the “May 2020 Repurchase Program”) whereby we were authorized to repurchase shares of our common stock from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management. The Company repurchased 4,614 shares at an aggregate purchase price of $0.3 million and an average share price of $69.91 under this plan for the three months ended March 31, 2022. The May 2020 Repurchase Program expired on May 1, 2022, with $10.8 million in authorized remaining capacity.
In May 2022, we announced that our board of directors had authorized a stock repurchase program (the “May 2022 Repurchase Program”) whereby we were authorized to repurchase shares of our common stock having an aggregate purchase prices of up to $50.0 million from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management. During the three months ended March 31, 2022, there were no amounts purchased under the May 2022 Repurchase Program. As of March 31, 2023, no amounts remained available under the May 2022 Repurchase Program.
In November 2022, we announced that our board of directors had authorized a new repurchase program (the “November 2022 Repurchase Program”) whereby we were authorized to repurchase shares of our common stock and convertible senior notes having an aggregate purchase price of up to $200.0 million from time to time on the open market or in privately negotiated transactions at prices and in the manner determined by management over the next two years. During the three month period ended March 31, 2023, we repurchased 581,295 shares for an aggregate purchase price of $25.0 million at an average share price of $42.99 under the November 2022 Repurchase Program. As of March 31, 2023, $160.1 million remained available under the November 2022 Repurchase Program.
30
Repurchased shares were recorded under the cost method and are reflected as treasury stock in the accompanying condensed consolidated Balance Sheets. All repurchased shares were funded with cash on hand.
Convertible Senior Notes and Term Loan and Credit Facility Borrowings
Convertible Senior Notes
In December 2021, we issued $414 million in aggregate principal amount of 0.00% convertible senior notes (“2026 Notes”) due December 15, 2026, unless earlier repurchased by us or converted by the holder pursuant to their terms. Special interest, if any, is payable semiannually in arrears on June 15 and December 15 of each year.
The 2026 Notes are governed by an indenture between us, as issuer, and U.S. Bank Trust Company, National Association, as trustee. The 2026 Notes are unsecured and rank senior in right of payment to our future indebtedness that is expressly subordinated in right of payment to the 2026 Notes and equal in right of payment to our unsecured indebtedness that is not so subordinated.
Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of common stock, at our election.
The 2026 Notes have an initial conversion rate of 7.6043 shares of common stock per $1,000 principal amount of 2026 Notes. This represents an initial effective conversion price of approximately $131.50 per share of common stock and 3,148,180 shares issuable upon conversion. Throughout the term of the 2026 Notes, the conversion rate may be adjusted upon the occurrence of certain events. As of March 31, 2023, no such adjustment has occurred. Holders of the 2026 Notes will not receive any cash payment representing accrued and unpaid interest, if any, upon conversion of a 2026 Note.
Proceeds from the 2026 Notes were utilized to retire $149.9 million of the 2025 Notes and for general corporate purposes.
In December 2020, we issued $201.3 million in aggregate principal amount of 0.125% convertible senior notes (the “2025 Notes”) due December 15, 2025, unless earlier repurchased by us or converted by the holder pursuant to their terms. Interest is payable semiannually in arrears on June 15 and December 15 of each year, which commenced on June 15, 2021.
The 2025 Notes are governed by an indenture between us, as issuer, and U.S. Bank Trust Company, National Association, as trustee. The 2025 Notes are unsecured and rank senior in right of payment to our future indebtedness that is expressly subordinated in right of payment to the Notes and equal in right of payment to our unsecured indebtedness that is not so subordinated.
Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of common stock, at our election.
The 2025 Notes have an initial conversion rate of 14.1977 shares of common stock per $1,000 principal amount of the Notes. This represents an initial effective conversion price of approximately $70.43 per share of common stock and 2,857,447 shares issuable upon conversion of the full aggregate principal amount of the 2025 Notes. Throughout the term of the 2025 Notes, the conversion rate may be adjusted upon the occurrence of certain events. As of March 31, 2023, no such adjustment has occurred. Holders of the 2025 Notes will not receive any cash payment representing accrued and unpaid interest, if any, upon conversion of a Note, except in limited circumstances. Accrued but unpaid interest will be deemed to be paid by cash, shares of our common stock or a combination of cash and shares of our common stock paid or delivered, as the case may be, to the holder upon conversion of the Notes.
After the induced conversion of $149.9 million aggregate principal amount of the 2025 Notes in December 2021, approximately $51 million of aggregate principal of 2025 Notes remain outstanding. As of March 31, 2023, 729,533 shares were issuable upon conversion of the full aggregate principal amounts of such remaining 2025 Notes.
2021 Loan Agreement
On October 29, 2021, we entered into the 2021 Loan Agreement with Western Alliance Bank. The 2021 Loan Agreement provides for a $75 million revolving credit facility with a $5 million letter-of-credit sublimit and a maturity date of October 29, 2023. The 2021 Loan Agreement is secured by substantially all of our assets. Borrowings under the 2021 Loan Agreement bear interest at a rate equal to one (1) month U.S. LIBOR, plus a spread based upon our leverage (as defined by 2021 Loan Agreement), which may vary between 2.00% and 2.75%. As of March 31, 2023, the interest rate was 7.42%. The 2021 Loan Agreement is subject to various leverage and non-financial covenants. No amounts were outstanding under the 2021 Loan Agreement as of March 31, 2023.
31
Capital Expenditures
We have made capital expenditures primarily for computer equipment and related software needed to host our websites, internal-use software development costs, as well as for leasehold improvements and other general purposes to support our growth. Our capital expenditures totaled $3.5 million and $3.6 million for the three-month periods ended March 31, 2023 and 2022, respectively. A majority of our capital expenditures in the first three months of 2023 were for internal-use software and website development costs and, to a lesser extent, computer equipment and related software. We capitalized internal-use software and website development costs of $3.4 million and $3.2 million for the three months ended March 31, 2023 and 2022, respectively. We are not currently party to any purchase contracts related to future capital expenditures.
Contractual Obligations
There were no material changes to our contractual obligations and commitments described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2022.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included or referenced in this Quarterly Report that address activities, events or developments which we expect will or may occur in the future are forward-looking statements, including statements regarding our intent, beliefs or current expectations and those of our management team. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “going to,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, priorities, plans, or intentions. Such statements may include those regarding our future financial results and other projections or measures of our future operating performance, including the drivers of such growth, profitability, and performance (including, in each case, any potential impact of product and service development efforts, GDPR or other similar laws, potential changes to customer relationships, and other operational decisions); expectations concerning market opportunities and our ability to capitalize on them; the amount and timing of the benefits expected from acquisitions, new strategies, products or services and other potential sources of additional revenue; and the behavior of our members, partners, and customers. These statements speak only as of the date of this Quarterly Report on Form 10-Q and are based on our current plans and expectations. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, those relating to: market acceptance of our products and services, including continued increased sales of our IT Deal Alert offerings and continued increased international growth; relationships with customers, strategic partners and employees; the duration and extent of the future health pandemics and any related economic downturns on our business, operations, and the markets in which we and our customers operate; difficulties in integrating acquired businesses; changes in economic or regulatory conditions or other trends affecting the internet, internet advertising and information technology industries; data privacy laws, rules, and regulations; the impact of foreign currency exchange rates, certain macro-economic factors facing the global economy including disruptions in the capital or banking markets, economic sanctions and economic slowdowns or recessions, rising inflation and interest rates, and other matters included in our SEC filings, including in our Annual Report on Form 10-K for the year ended December 31, 2022. Actual results may differ materially from those contemplated by the forward-looking statements. We undertake no obligation to update our forward-looking statements to reflect future events or circumstances.
32
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.
Foreign Currency Exchange Risk
We currently have subsidiaries in the United Kingdom, Hong Kong, Australia, Singapore, Germany and France. Approximately 24% of our revenue for the three months ended March 31, 2023 was derived from customers with billing addresses outside of the United States and our foreign exchange gains/losses were not significant. We currently believe our exposure to foreign currency exchange rate fluctuations is financially immaterial and therefore have not entered into foreign currency hedging transactions. We continue to review this issue and may consider hedging certain foreign exchange risks through the use of currency futures or options in the future. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. Our continued international expansion increases our exposure to exchange rate fluctuations and as a result such fluctuations could have a significant impact on our future results of operations. We also maintain receivables and cash accounts denominated in currencies other than the local currency, which exposes us to foreign exchange rate movements.
In addition, our foreign subsidiaries have certain amounts of Goodwill and Intangibles which expose us to foreign currency exchange rate fluctuations. These exchange rate fluctuations are included as a component of other comprehensive (loss) income.
Interest Rate Risk
At March 31, 2023, we had cash, cash equivalents and investments of $352.7 million. The investments were held in a bond fund. The cash, cash equivalents and investments were held for working capital purposes. We have not entered into investments for trading or speculative purposes. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value as a result of increases in interest rates. Declines in interest rates, however, would reduce future investment income. Additionally, our 2021 Loan Agreement provides for a $75 million revolving credit facility with a $5 million letter-of-credit sublimit. Borrowings under the 2021 Loan Agreement bear interest at a rate equal to one (1) month U.S. LIBOR, plus a spread based upon our leverage (as defined by 2021 Loan Agreement), which may vary between 2.00% and 2.75%. No amounts were outstanding under the 2021 Loan Agreement as of March 31, 2023. Should interest rates rise, it would cost us more to borrow under the 2021 Loan Agreement.
Inflation Risk
Inflation generally affects us by increasing our cost of labor and certain services. We do not believe that inflation had a material effect on our financial statements included elsewhere in this Quarterly Report on Form 10-Q. However, the United States has recently experienced historically high levels of inflation. If the inflation rate continues to increase it may affect our expenses, such as increases in the costs of labor and supplies. Additionally, the United States is experiencing a workforce shortage, which in turn has created a competitive wage environment that may increase our operating costs in the future.
33
Item 4. Controls and Procedures
Disclosure Controls and Procedures
We are required to maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) as appropriate, to allow timely decisions regarding required disclosure.
In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended March 31, 2023, management, under the supervision of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures as of March 31, 2023. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation of such internal controls that occurred during the first quarter of 2023 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
34
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently a party to any material legal proceedings and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results or financial condition.
Item 1A. Risk Factors
Our business is subject to various risks and uncertainties, including those described in Item 1A – “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022, that could have a material effect on our business, results of operations, financial condition and/or liquidity and that could cause our operating results to vary significantly from period to period. Investors should carefully review the disclosure contained therein, as well as the other information contained in this Quarterly Report on Form 10-Q.
35
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Our repurchases under our repurchase programs are made from time to time at management’s discretion in accordance with applicable federal securities laws. All repurchases of our common stock have been recorded as treasury stock. The following table summarizes information relating to purchases made by or on our behalf of shares of our common stock during the quarter ended March 31, 2023.
Period |
|
Total Number of |
|
|
Average Price |
|
|
Total Number of |
|
|
Approximate Dollar |
|
||||
January 1, 2023 - January 31, 2023 |
|
|
215,584 |
|
|
$ |
46.93 |
|
|
|
215,584 |
|
|
$ |
174,998 |
|
February 1, 2023 - February 28, 2023 |
|
|
270,881 |
|
|
$ |
41.25 |
|
|
|
270,881 |
|
|
$ |
163,824 |
|
March 1, 2023 - March 31, 2023 |
|
|
94,830 |
|
|
$ |
38.98 |
|
|
|
94,830 |
|
|
$ |
160,127 |
|
Total |
|
|
581,295 |
|
|
|
|
|
|
581,295 |
|
|
$ |
160,127 |
|
(1) In November 2022, we announced that the Board of Directors approved a repurchase program (the “November 2022 Repurchase Program”), which authorized management to purchase shares of our common stock or Notes having an aggregate purchase price of up to $200.0 million from time to time on the open market or in privately negotiated transactions with an expiration in November of 2024.
(2) We purchased an aggregate of 581,295 shares of our common stock in the open market pursuant to our November 2022 Repurchase Program. No shares were transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of restricted stock rights during the period.
(3) From the November 2022 Repurchase Program's inception through March 31, 2023, we purchased 923,078 shares at an average price of $43.20 per share for a total of $39.9 million.
36
Item 6. Exhibits
The exhibits listed below are filed as part of this Quarterly Report on Form 10-Q.
|
|
|
|
|
|
Incorporated by Reference to |
||||
Exhibit No. |
|
Description of Exhibit |
|
Form or Schedule |
|
Exhibit No. |
|
Filing Date with SEC |
|
SEC File Number |
|
|
|
|
|
|
|
|
|
|
|
3.1 |
|
Fourth Amended and Restated Certificate of Incorporation of the Registrant. |
|
10-Q |
|
3.1 |
|
11/13/2007 |
|
001-33472 |
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
Amended and Restated Bylaws of TechTarget, Inc.
|
|
10-Q |
|
3.2 |
|
08/04/2021 |
|
001-33472 |
|
|
|
|
|
|
|
|
|
|
|
31.1* |
|
|
|
|
|
|
|
|
|
|
31.2* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS |
|
Inline XBRL Instance Document* The instance document does not appear in the Interactive Data File because its XBRL tags are |
|
|
|
|
|
|
|
|
|
|
Embedded within the Inline XBRL document. |
|
|
|
|
|
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exbibit 101) |
|
|
|
|
|
|
|
|
* Filed herewith.
37
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
TECHTARGET, INC. |
|
|
(Registrant) |
|
|
|
|
Date: May 9, 2023 |
By: |
/s/ MICHAEL COTOIA |
|
|
Michael Cotoia, Chief Executive Officer and Director (Principal Executive Officer) |
|
|
|
Date: May 9, 2023 |
By: |
/s/ DANIEL NORECK |
|
|
Daniel Noreck, Chief Financial Officer and Treasurer (Principal Accounting and Financial Officer) |
38